These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16782899

  • 21. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
    Cox BD, Natarajan M, Stettner MR, Gladson CL.
    J Cell Biochem; 2006 Sep 01; 99(1):35-52. PubMed ID: 16823799
    [Abstract] [Full Text] [Related]

  • 22. Protein-tyrosine kinase CAKbeta/PYK2 is activated by binding Ca2+/calmodulin to FERM F2 alpha2 helix and thus forming its dimer.
    Kohno T, Matsuda E, Sasaki H, Sasaki T.
    Biochem J; 2008 Mar 15; 410(3):513-23. PubMed ID: 18031286
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Phosphorylation of focal adhesion kinase at Tyrosine 407 negatively regulates Ras transformation of fibroblasts.
    Jeon J, Lee H, Park H, Lee JH, Choi S, Hwang J, Han IO, Oh ES.
    Biochem Biophys Res Commun; 2007 Dec 28; 364(4):1062-6. PubMed ID: 17976369
    [Abstract] [Full Text] [Related]

  • 27. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
    Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L, Tripodi M.
    Exp Cell Res; 2008 Jan 01; 314(1):143-52. PubMed ID: 17949712
    [Abstract] [Full Text] [Related]

  • 28. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 29. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
    Kamarajan P, Kapila YL.
    Apoptosis; 2007 Dec 15; 12(12):2221-31. PubMed ID: 17879163
    [Abstract] [Full Text] [Related]

  • 30. Quantitative measurement of changes in adhesion force involving focal adhesion kinase during cell attachment, spread, and migration.
    Wu CC, Su HW, Lee CC, Tang MJ, Su FC.
    Biochem Biophys Res Commun; 2005 Apr 01; 329(1):256-65. PubMed ID: 15721301
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth.
    Bertotti A, Comoglio PM, Trusolino L.
    J Cell Biol; 2006 Dec 18; 175(6):993-1003. PubMed ID: 17158954
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Sema domain of Met is necessary for receptor dimerization and activation.
    Kong-Beltran M, Stamos J, Wickramasinghe D.
    Cancer Cell; 2004 Jul 18; 6(1):75-84. PubMed ID: 15261143
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
    Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, Peng T, Ma J, Zhang L, Zhang H, Leng J.
    Oncol Rep; 2009 Jan 18; 21(1):129-36. PubMed ID: 19082453
    [Abstract] [Full Text] [Related]

  • 40. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
    Watanabe N, Takaoka M, Sakurama K, Tomono Y, Hatakeyama S, Ohmori O, Motoki T, Shirakawa Y, Yamatsuji T, Haisa M, Matsuoka J, Beer DG, Nagatsuka H, Tanaka N, Naomoto Y.
    Clin Cancer Res; 2008 Jul 15; 14(14):4631-9. PubMed ID: 18628478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.